19 Jun, 2013
The Leela Palace, Bengaluru
Home >> Private Equity >>
Wednesday, June 13, 2012 - 18:50 IST
Super Religare Labs raises $66M
BY Megha Arora
IFC, Jacob ballas put in money in the third PE deal struck by the medical diagnostics firm in the last 14 months.
Super Religare Laboratories (SRL), a unit of Fortis Healthcare, has announced its third private equity (PE) deal in the past 14 months. This time, NYLIM Jacob Ballas India Fund, a mid-market private equity firm with more than $600...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 23 May 2013Murali ApparajuonInteresting surmises! What makes the takeaways less validated however is the lack of disclosure or at least a...
- 23 May 2013VaradhaonPhoenix LP's are managing your money and my money - so they ought to maintain an arm's length and review...
- 21 May 2013PhoenixonWell said Varadha. This comment of your is unclear, " LPs ought to maintain an arm's distance from GPs and...
- 21 May 2013AnooponThe biggest problem in Indian PE fund GPs is Ethics. They want Day-One-Carry rather than long term carry. There should...
UPCOMING EVENTSchinetwork